SEC Filings

SEC Filings

Filing date	Description	Form	View
Oct 04, 2010	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-10-049396.pdf 0001181431-10-049396.rtf
Oct 04, 2010	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-10-049397.pdf 0001181431-10-049397.rtf
Oct 04, 2010	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-10-048862.pdf 0001209191-10-048862.rtf
Oct 04, 2010	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-10-048865.pdf 0001209191-10-048865.rtf
Oct 01, 2010	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	View HTML 0001193125-10-222019.pdf 0001193125-10-222019.rtf 0001193125-10-222019.xls
Sep 30, 2010	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-10-220417.pdf 0001193125-10-220417.rtf 0001193125-10-220417.xls
Sep 23, 2010	Tender offer schedule and amendment filed by the issuer.	SC TO-I	View HTML 0001193125-10-215376.pdf 0001193125-10-215376.rtf 0001193125-10-215376.xls
Sep 20, 2010	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	View HTML 0001193125-10-213123.pdf 0001193125-10-213123.rtf 0001193125-10-213123.xls
Aug 06, 2010	Quarterly report which provides a continuing view of a company's financial position	10-Q	View HTML 0001193125-10-180700.pdf 0001193125-10-180700.rtf 0001193125-10-180700.xls
Aug 02, 2010	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-10-172858.pdf 0001193125-10-172858.rtf 0001193125-10-172858.xls

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE